SKI Market

A+| A| A-|

Indian Indices

Sensex

75,867.80 -141.90
( -0.19%)

Global Indices

Nasdaq

50,493.86 -106.84
(-0.21%)

Dow Jones

7,540.47 46.00
(0.61%)

Hang Seng

65,194.32 198.23
(0.30%)

Nikkei 225

10,499.42 33.16
(0.32%)

Forex

USD-INR

95.26 -0.35
(-0.37%)

EUR-INR

110.89 -0.08
(-0.07%)

GBP-INR

128.53 0.11
(0.08%)

JPY-INR

0.60 0.00
(-0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Indrayani Biotech Ltd

Industry : Diversified - Medium / Small

BSE Code

ISIN Demat

Book Value()

526445

INE007C01021

13.440188

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

94.09

80.79

EPS(TTM)

Face Value()

Div & Yield %

0.11

Back

rossari biotech ltd

Vaxtex Cotfab reports standalone net profit of Rs 3.95 crore in the December 2025 quarter

Feb 12,2026

Net profit of Vaxtex Cotfab reported to Rs 3.95 crore in the quarter ended December 2025 as against net loss of Rs 0.39 crore during the previous quarter ended December 2024. Sales reported to Rs 8.88 crore in the quarter ended December 2025. There were no Sales reported during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	8.88	0	0
OPM %	26.13	0	-
PBDT	3.86	-0.38	LP
PBT	3.86	-0.44	LP
NP	3.95	-0.39	LP

75,867.80 -141.90 ( -0.19%)

50,493.86 -106.84 (-0.21%)

7,540.47 46.00 (0.61%)

65,194.32 198.23 (0.30%)

10,499.42 33.16 (0.32%)

95.26 -0.35 (-0.37%)

110.89 -0.08 (-0.07%)

128.53 0.11 (0.08%)

0.60 0.00 (-0.21%)